The genetics of Parkinson's disease and parkinsonian syndromes

Journal of Neurology

Volumn 245, Issue 10, 1998, Pages 625-633

  Bajaj, Narinder P S ^a   Shaw, Christopher ^a,c   Warner, Tom ^b   RayChaudhuri, K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

synuclein; Genetic susceptibility; Parkinson's disease; Parkinsonism

Indexed keywords

ALPHA SYNUCLEIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; DIAGNOSTIC IMAGING; DOPAMINE METABOLISM; DRUG METABOLISM; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVIEW; RISK;

ENGLAND; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; POLYMORPHISM, GENETIC; PREVALENCE; TWIN STUDIES;

EID: 0031684773     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050258     Document Type: Review

References (101)

1. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR (1992) Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339: 1017-1018
2. Bandmann O, Daniel S, Marsden CD, Wood NW, Harding AE (1996) The GTP-cyclohydrolase I gene in atypical parkinsonian patients: a clinico-genetic study. J Neurol Sci 141: 27-32
3. Bandmann O, Sweeney MG, Daniel SE, Marsden CD, Wood NW (1997) Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease. J Neurol 244: 262-265
4. Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW (1997) Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 350: 1136-1139
5. Barbeau A, Roy M, Paris S, Cloutier T, Plasse L, Poirier J (1985) Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 2: 1213-1215
6. Bindoff LA, Birch-Machin MA, Cartlidge NEF, Parker WD, Turnball DM (1989) Mitochondrial function in Parkinson's disease. Lancet 2: 49
7. Bordet R, Broly F, Destee A, Libersa C, Lafitte JJ (1996) Lack of relation between genetic polymorphism of cytochrome P-450IID6 and sporadic idiopathic Parkinson's disease. Clin Neuropharmacol 19: 213-221
8. Brown MD, Shoffner JM, Kim YL, Jun AS, Graham BH, Cabell MF, Gurley DS, Wallace DC (1996) Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am J Med Genet 61: 283-289
9. Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman TR Jr, Duvoisin RC, Harding AE, Marsden CD, Brooks DJ (1992) Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology 42: 1894-1900
10. Chartier-Harlin MC, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V, Fruchart JC, Delacourte A, Rossor M, Amouyel P (1994) Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3: 569-574
11. Cruts M, Hendriks L, Van Broeckhoven C (1996) The presenilin genes: a new gene family involved in Alzheimer disease pathology. Hum Mol Genet 5: 1449-1455
12. Daly AK, Cholerton S, Armstrong M, Idle JR (1994) Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 102: 55-61
13. Daly AK, Brockmoller J, Broly F, Eichelbaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelmansundberg M, Ishizaki T, Jacqzaigrain E, Meyer UA, Nebert DW, Steen VM, Wolf CR, Zanger UM (1996) Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6: 193-201
14. Degl'Innocenti F, Maurello MT, Marini P (1989) A parkinsonian kindred. Ital J Neurol Sci 10: 307-310
15. DiDonato S, Zevianni M, Giovannini P, Savarese N, Rimoldi M, Mariotti C, Girotti F, Caraceni T (1993) Respiratory chain and mitochondrial DNA in muscle and brain in Parkinsons's disease patients. Neurology 43: 2262-2268
16. Diederich N, Hilger C, Goetz CG, Keipes M, Hentges F, Vicregge P, Metz H (1996) Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson disease. Ann Neurol 40: 463-465
17. Duvoisin RC, Eldridge R, Williams A, Calne D (1981) Twin study of Parkinson's disease. Neurology 31: 77-80
18. Fahn S, Mayeux R, Rowland LP (1995) A new eponym: Wilhelmsen-Lynch disease. Neurology 44: 1980
19. Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO (1994) Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol 36: 387-396
20. Gasser T, Muller-Myhsok B, Supala A, Zimmer E, Wieditz G, Wszolek ZK, Vieregge P, Bonifati V, Oertel WH (1996) The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 61: 518-520
21. Gasser T, Muller-Myhsok B, Wszolek ZK, Durr A, Vaughan JR, Bonifati V, Meco G, Bereznai B, Oehlmann R, Agid Y, Brice A, Wood N (1997) Genetic complexity and Parkinson's disease (letter). Science 277: 388-389
22. Gibb WRG, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15: 27-44
23. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC (1990) A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 27: 276-282
24. Gowers WR (1902) A manual of the diseases of the nervous system, 2nd edn. Blakiston, Philadelphia, p 636
25. Gradinetti A, Morens DM, Reed D, MacEachern D (1994) Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 139: 1129-1138
26. Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, Shults CW (1995) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol 37: 714-722
27. Harding AE (1991) Neurological disease and mitochondrial genes. Trends Neurosci 14: 132-138
28. Heintz N, Zoghbi H (1997) Alpha-synuclein - a link between Parkinson and Alzheimer diseases? Nat Genet 16: 325-327
29. Heutink P, Stevens M, Rizzu P, Bakker E, Kros JM, Tibben A, Niermeijer MF, Dujn CM van, Oostren BA, Swieten JC van (1997) Heriditary frontotemporal dementia is linked to chromosome 17q21-22. Genetic and clinico-pathological study of 3 Dutch families. Ann Neurol 41: 150-159
30. Ho SL, Kapadi AL, Ramsden DN, Williams AC (1995) An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 37: 403-405
31. Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bonner J, Wagner R, Wienhard K, Pawlik G, Heiss WD (1994) Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 36: 176-182
32. Hsiao K, Baker HF, Crow TJ (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338: 342-345
33. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42: 1142-1146
34. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
35. Ichinose H, Ohye T, Takahashi E-I, Seki N, Hori T-A, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K, Nagatsu T (1994) Heriditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydolase I gene. Nat Genet 8: 236-242
36. Johnson WG, Hodge SE, Duvoisin R (1990) Twin studies and the genetics of Parkinson's disease - a reappraisal. Move Disord 5: 187-194
37. Kallio J, Marttila RJ, Rinne UK, Sonninen V, Syvalahti E (1991) Debrisoquine oxidation in Parkinson's disease. Acta Neurol Scand 83: 194-197
38. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, Kimura J, Narumiya S, Kakizuka A (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8: 221-228
39. +: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA. Ann Neurol 43: 109-111
40. Kunugi H, Nanko S, Ueka A, Otsuko E, Hattori M, Hoda F, Vallada HP, Arranz MJ, Collier DA (1997) High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci Lett 221: 202-204
41. Kurth MC, Kurth JH (1993) Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Am J Med Genet 48: 166-168
42. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD (1993) Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 33: 368-372
43. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of a meperidine-analog synthesis. Science 219: 979-980
44. Lanska DJ, Currier RD, Cohen M (1994) Familial progressive subcortical gliosis. Neurology 44: 1633-1643
45. Lazzarini AM, Myers RH, Zimmerman TR Jr, Mark MH, Golbe LI, Sage JI, Johnson WG, Duvoisin RC (1994) A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 44: 499-506
46. Le Couteur DG, Leighton PW, McCann SJ, Pond SM (1997) Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Mov Disord 12: 760-763
47. Lee LV, Pascasio FM, Fuentes FD, Viterbo GH (1976) Torsion dystonia in Panay, Philippines. Adv Neurol 14: 137-151
48. Lestienne P, Nelson J, Riederer P, Jellinger J, Reichmann H (1990) Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J Neurochem 55: 1810-1812
49. Lucotte G, Turpin JC, Gerard N, Panserat S, Krishnamoorthy R (1996) Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families. Am J Med Genet 67: 361-365
50. Ludecke B, Dworniczak B, Bartholome K (1995) A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 95: 123-125
51. Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AAF, Keohane C, Nygaard T, Fahn S, Mayeux R, Rowland LP, Wilhelmsen KC (1994) Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 44: 1878-1884
52. MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N, MacFarlane H, Jenkins B, Anderson MA, Wexler NS, Gusella JF, Bates GP, Baxendale S, Hummerich H, Kirby S, et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983
53. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AHV, Marsden CD (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115: 333-342
54. Marder K, Tang M-X, Mejia H, Alfaro BA, Cote MD, Louis MD, Groves J, Mayeux R (1996) Risk of Parkinson's disease among first degree relatives: a community based study. Neurology 47: 155-160
55. Martilla RJ, Kaprio J, Koskenvuo MD, Rinne UK (1988) Parkinson's disease in a nationwide twin cohort. Neurology 38: 1217-1219
56. Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A, Nakagawa-Hattori Y, Yokochi M, Kobayashi T, Igarashi S, Takono H, Sanpei K, Koike R, Mori H, Kondo T, Mizutani Y, Schaffer AA, Yamamura Y, Nakamura S, Kuzuhara S, Tsuji S, Mizuno Y (1997) Localisation of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 60: 588-596
57. Mena I, Marin O, Fuenzalida S, Cotzias GC (1967) Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 17: 128-136
58. Mizuno Y, Ikebe SI, Hattori N, Nakagawa-Hattori Y, Mochizuki H, Tanaka M, Ozawa T (1995) Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta - Molecular Basis of Disease 1271: 265-274
59. Mjones H (1949) Paralysis agitans. A clinical genetic study. Acta Psychiatr Neurol Scand 25 [Suppl 54]: 1-195
60. Munoz E, Oliva R, Obach V, Marti MJ, Pastor P, Ballesta F, Tolosa E (1997) Identification of a Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients. Neurosci Lett 235: 57-60
61. Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, Ikeda K, Kazamatsuri H (1994) No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms. Am J Med Genet 54: 361-364
62. Nanko S, Ueki A, Hattori M (1996) No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms. Neurosci Lett 204: 125-127
63. Nygaard TG, Wilhelmsen KC, Risch NJ, Brown DL, Trugman JM, Gilliam TC, Fahn S, Weeks DE (1993) Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 5: 386-391
64. Ozawa T, Tanaka M, Ikebe S, Ohno K, Kondo T, Mizuno Y (1990) Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem Biophys Res Commun 172: 483-489
65. Parker WD, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26: 719-723
66. Piccini P, Morrish PK, Turjanski N, Sawle GV, Burn DJ, Weeks RA, Mark MH, Maraganore DM, Lees AJ, Brooks DJ (1997) Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study. Ann Neurol 41: 222-229
67. Plante-Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE (1994) Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 57: 911-913
68. Polymeropoulos MH, Higgins JJ, Goibe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC (1996) Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274: 1197-1199
69. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Deheija A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Iorio GD, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in familes with Parkinson's disease. Science 276: 2045-2047
70. RayChaudhuri K, Smith CAD, Gough AC, Novak N, Chamoun V, Wolf CR, Leigh PN (1995) Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis [4]. J Neurol Neurosurg Psychiatry 58: 109
71. Sasaki H, Wakisaka A, Takada A, Yoshiki T, Ihara T, Suzuki Y, Hamada T, Iwabuchi K, Onari K, Tada J, Suzuki T, Tashiro K (1995) Mapping of the gene for MachadoJoseph disease within a 3.6-cM interval flanked by D14s291/D14s280 and D14s81, on the basis of studies of linkage and linkage disequilibrium in 24 Japanese families. Am J Hum Genet 56: 231-242
72. Schapira AHV (1994) Advances in the understanding of the cause of Parkinson's disease. J R Soc Med 87: 373-375
73. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269
74. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827
75. Schapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55: 2142-2145
76. Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Ulm G, Schneider E (1996) Possible environmental, occupational, and other etiological factors for Parkinson's disease. Neurology 46: 1275-1284
77. Semchuk KM (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42: 1328-1335
78. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R, Watts RL, Juncos JL, Hansen LA, Crain BC, Fayad M, Reckford CL, Wallace DC (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184
79. Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE, Maranganore DM, Sturman SG, Schapira AHV, Williams AC, Spurr NK, Wolf CR (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 339: 1375-1377
80. Spellman GG (1962) Report of familial cases of parkinsonism: evidence of a dominant trait in a patient family. JAMA 179: 372-374
81. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840
82. Steiger MJ, Lledo P, Quinn NP, Marsden CD, Turner P, Jenner PG (1992) Debrisoquine hydroxylation in Parkinson's disease. Acta Neurol Scand 86: 159-164
83. Sutcliffe RLG, Meara JR (1995) Parkinson's disease epidemiology in the Northampton district, England, 1992. Acta Neurol Scand 92: 443-450
84. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP Jr, Davis RE, Parker WD Jr (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40: 663-671
85. Synder S, D'Amato R (1986) MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology 36: 250-258
86. Takakubo F, Yamamoto M, Ogawa N, Yamashita Y, Mizuno Y, Kondo I (1996) Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. J Neural Trans 103: 843-849
87. Takano T, Yamanouchi Y, Nagafuchi S, Yamada M (1996) Assignment of the dentatorubral and pallidoluysian atrophy (DRPLA) gene to 12p13.31 by fluorescence in situ hybridization. Genomics 32: 171-172
88. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, Devoto M, Peppercorn J, Bush AI, Sternlieb I, Pirastu M, Gusella JF, Evgrafov O, Penchaszadeh GK, Honig B, Endelman IS, Soares MB, Scheinberg IH, Gilliam TC (1993) The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5: 344-350
89. Taylor TD, Litt M, Kramer P, Pandolfo M, Angelini L, Nardocci N, Davis S, Pineda M, Hattori H, Flett PJ, Cilio MR, Bertini E, Hayflick SJ (1996) Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 14: 479-481
90. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognised component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90: 11 282-11 286
91. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106
92. Ward CD, Duvoisin RC, Ince SE (1983) Parkinson' disease in 65 pairs of twins and in a set of quadruplets. Neurology 33: 815-824
93. Wijker M, Wszolek ZK, Wolters ECH, Rooimans MA, Pals G, Pfeiffer RF, Lynch T, Rodnitzky RL, Wilhemsen KC, Arwert F (1996) Localisation of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-pontonigral degeneration to chromosome 17q21. Hum Mol Genet 5: 151-154
94. Wilhelmsen KC (1997) Frontotemporal dementia is on the MAPt. Ann Neurol 41: 139-140
95. Wilhelmsen KC, Wszolek ZK (1995) Is there a genetic susceptibility to idiopathic parkinsonism? Parkinsonism Relat Disord 1: 73-84
96. Wilhelmsen KC, Weeks DE, Nygaard TG, Moskowitz CB, Rosales RL, Paz DC dela, Sobrevega EE, Fahn S, Gilliam TC (1991) Genetic mapping of "Lubag" (X linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol 29: 124-131
97. Wilhelmsen KC, Lynch T, Pavlou E (1994) Localisation of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 55: 1159-1165
98. Wood N (1997) Genes and parkinsonism. J Neurol Neurosurg Psychiatry 62: 305-309
99. Wooten GF, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Parker WD (1997) Maternal inheritance in Parkinson's disease. Ann Neurol 41: 265-268
100. Xie T, Ho SL, Li SW, Ma OCK (1997) G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Mov Disord 12: 426-427
101. Zhang ZX, Roman GC (1993) Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 12: 195-208